ARCA biopharma Stock Price, News & Analysis (NASDAQ:ABIO) $1.83 +0.01 (+0.55%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$1.81▼$1.8850-Day Range$1.75▼$2.0552-Week Range$1.74▼$2.70Volume19,096 shsAverage Volume16,755 shsMarket Capitalization$26.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media About ARCA biopharma Stock (NASDAQ:ABIO)ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.Read More ABIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABIO Stock News HeadlinesNovember 28, 2023 | americanbankingnews.comARCA biopharma (NASDAQ:ABIO) Stock Price Passes Above 50 Day Moving Average of $1.94November 28, 2023 | americanbankingnews.comARCA biopharma (NASDAQ:ABIO) Receives New Coverage from Analysts at StockNews.comDecember 2, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.November 4, 2023 | msn.comSean Hingorani Rides Third-Place Phoenix Finish to Historic ARCA Menards Series West TitleNovember 3, 2023 | msn.comPhoenix Results: November 3, 2023 (ARCA Menards Series)October 25, 2023 | msn.comARCA champion Jesse Love to drive for RCR in Xfinity Series in 2024October 22, 2023 | finanznachrichten.deARCA biopharma, Inc.: ARCA biopharma Announces Third Quarter 2023 Financial ResultsOctober 18, 2023 | msn.comARCA biopharma GAAP EPS of -$0.10December 2, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.October 18, 2023 | finance.yahoo.comARCA biopharma Announces Third Quarter 2023 Financial ResultsSeptember 27, 2023 | msn.comARCA legend Kimmel keeps the racing itch scratched as a truck chief with TRICONSeptember 21, 2023 | msn.comARCA Wunderkind: NASCAR Fans Should 'Love' Who's Coming Down the RoadSeptember 10, 2023 | uk.finance.yahoo.comABIO - ARCA biopharma, Inc.September 8, 2023 | msn.comRookie Connor Mosack wins first career ARCA race at Kansas SpeedwaySeptember 6, 2023 | msn.comFive drivers to watch in Friday’s ARCA Sioux Chief Fast Track 150 at Kansas SpeedwayAugust 22, 2023 | msn.comRacing for Stride ARCA driver honors disabled veteransAugust 18, 2023 | msn.comWatkins Glen Day 1 Recap: ARCA race comes down to final turn; tough day for Frankie MunizAugust 18, 2023 | msn.comLove bumps Zilisch on last lap to win ARCA race at Watkins GlenAugust 18, 2023 | msn.comFrankie Muniz sees Watkins Glen as chance to earn first career ARCA victoryAugust 14, 2023 | msn.comCorey LaJoie enters ARCA Menards Series race for Watkins Glen weekendAugust 13, 2023 | msn.comARCA drivers Christian Rose, Conner Jones get into heated scuffle after spin outAugust 11, 2023 | yahoo.comActor Turned Racer Frankie Muniz Is No Joke in ARCA Racing SeriesJuly 30, 2023 | finanznachrichten.deARCA biopharma, Inc.: ARCA biopharma Announces Second Quarter 2023 Financial ResultsJuly 27, 2023 | sports.yahoo.comSekisui Voltek Announces Sponsorship of Coldwater's Rodgers for ARCA raceJuly 21, 2023 | sports.yahoo.comPOCONOTES: Actor Muniz in middle of ARCA points battleJuly 21, 2023 | finance.yahoo.comARCA biopharma Announces Second Quarter 2023 Financial ResultsJuly 15, 2023 | msn.comFenhaus wins Calypso 150 in ARCA Menards SeriesSee More Headlines Receive ABIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/18/2023Today12/02/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ABIO CUSIPN/A CIK907654 Webarcabio.com Phone(720) 940-2100Fax720-208-9261Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,930,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-13.61% Return on Assets-13.12% Debt Debt-to-Equity RatioN/A Current Ratio39.21 Quick Ratio39.21 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.89 per share Price / Book0.63Miscellaneous Outstanding Shares14,410,000Free FloatN/AMarket Cap$26.37 million OptionableNot Optionable Beta1.43 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Michael R. Bristow M.D. (Age 78)Ph.D., Co-Founder, President, CEO & Director Comp: $358.8kMr. Thomas A. Keuer (Age 64)Chief Operating Officer Comp: $360.59kMr. C. Jeffrey Dekker CPA (Age 58)Chief Financial Officer Key Competitors60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAllena PharmaceuticalsNASDAQ:ALNAQAlpha Tau MedicalNASDAQ:DRTSWView All CompetitorsInstitutional OwnershipNewtyn Management LLCSold 13,200 shares on 11/14/2023Ownership: 0.000%View All Institutional Transactions ABIO Stock Analysis - Frequently Asked Questions How have ABIO shares performed in 2023? ARCA biopharma's stock was trading at $2.37 at the beginning of 2023. Since then, ABIO shares have decreased by 22.8% and is now trading at $1.83. View the best growth stocks for 2023 here. When is ARCA biopharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024. View our ABIO earnings forecast. How were ARCA biopharma's earnings last quarter? ARCA biopharma, Inc. (NASDAQ:ABIO) released its earnings results on Wednesday, October, 18th. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter. What is Michael R. Bristow's approval rating as ARCA biopharma's CEO? 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of ARCA biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP). Who are ARCA biopharma's major shareholders? ARCA biopharma's stock is owned by many different institutional and retail investors. Top institutional shareholders include Newtyn Management LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway. View institutional ownership trends. How do I buy shares of ARCA biopharma? Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:ABIO) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.